About 19,100,000 results
Newsroom - Pfizer
Pfizer Inc. (PFE) Latest Stock News & Headlines - Yahoo Finance
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
Pfizer rolls out another cost-cutting program, sets $1.5 billion …
Press Releases - Pfizer
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
CDC identifies possible safety issue with Pfizer’s updated ... - CNN
The FDA just approved the new Covid vaccine: When to get it ... - NBC News
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
Pfizer pins hopes on record pipeline to recover from post-Covid …
Pfizer’s gene therapy for rare genetic bleeding disorder ... - CNBC
FDA Approves First COVID-19 Vaccine
Pfizer : Phase 2 Study Of Ponsegromab In Cancer ... - Markets …
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
Why Pfizer's FDA Approval Matters And What It Means For …
Pfizer, Inc. Common Stock (PFE) Stock Price, Quote, News & History - Nasdaq
FDA Takes Action on Updated mRNA COVID-19 Vaccines to Better …
Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
ESMO 2024: Pfizer’s cachexia drug provides meaningful weight gain
Pfizer and BioNTech Announce Vaccine Candidate Against COVID …
Readout Newsletter: Keytruda, IRA, Pfizer, psychedelics - STAT
INTC, MSFT, META, PFE, TSLA: Top Trending Stocks Today - Benzinga
Fawn Creek township, Montgomery County, Kansas (KS) detailed …
Kansas Governor Kelly signs ‘sanctuary city’ bill, dealing harsh blow ...
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 …
Year-long bridge replacement project set to impact Marshall Co ... - WIBW
Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 …
Kansas immigrants say they face 'unsafe and ... - NPR in Kansas City
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically …
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab …
- Some results have been removed